Transplant Diagnostics Market Report - Key Major Players, Drivers, Restraints, Opportunities (2016 to 2021)

Global transplant diagnostics market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such as rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in field of organ transplantations; and increased funding, research grants, and public-private investments.

Complete report on Transplant Diagnostics Market spread across 180 pages, Profiling 11 Companies and supported with 180 Tables and 60 Figures is now available at .

On basis of applications, global transplant diagnostics market is segmented into diagnostic and research applications. Diagnostic applications segment is expected to account for larger share of global market in 2016. Diagnostic applications segment is also projected to grow faster as compared to research applications in global market during 2016–2021.

This research report is useful for the following audience

·         Transplant Diagnostic Product Manufacturing Companies

·         Healthcare Service Providers (Including Hospitals and Transplant Centers)

·         Research and Development (R&D) Companies

·         Commercial Service Providers

·         Diagnostic Laboratories

·         Clinical Research Organizations (CROs)

·         Research Laboratories and Academic Institutes

·         Market Research and Consulting Firms

Significant growth potential of the transplant diagnostics market applications segment can be attributed to factors such as rising number of solid organ transplantations, increasing installation base of PCR & sequencing-based devices, growing adoption of HLA profiling among hospitals and transplant centers, and rising awareness among public related to benefits of molecular assay-based procedures.

Transplant diagnostics market research applications segment is expected to witness a positive market growth during study period due to factors such as increasing public private investments that support genomics-based transplantation research, growing use of robotics in laboratory automation, and growing number of PCR and NGS-based clinical trials.

Interested in this New Research Study the Sample Copy of this research is Available Now .

Europe is expected to hold second-largest share of transplant diagnostics market in 2016. This leading market position of European market is due to factors like rising acceptance of genome-based diagnostic techniques by healthcare professionals, large number of organ transplantation procedures performed annually, presence of a large number of biotechnology & molecular diagnostic companies, and rapid growth in aging population.

Thermo Fisher Scientific, Inc. (U.S.) dominated the global transplant diagnostics market with a share of 42.0% in 2015. In the past three years, company adopted strategic acquisitions and geographic expansions as key growth strategies to maintain its dominant position in global transplant diagnostics market.

Other leading players present in market are Immucor, Inc. (U.S), Olerup SSp AB (Sweden), QIAGEN, Inc. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), Affymetrix, Inc. (U.S.), Illumina Inc. (U.S.), Luminex Corporation, (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Abbott Laboratories, Inc. (U.S.), among others.

Click now for more Details, Queries, Other Information and Discount this study “Transplant Diagnostics Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021” report @ .

Factors such as growing number of solid organ, soft tissue, and stem cell transplantation; technological advancements; and increased funding, research grants, and public-private investments are the key market drivers for the transplant diagnostics industry. However, high device costs associated with NGS and PCR-based devices and limited medical reimbursements for organ donation and transplantation procedure restrain the growth of the market to a certain extent.

Explore more reports on Medical Devices at .

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441